Advertisement

Topics

#Astellas $PFE Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer https://www.prnewswire.com/news-releases/astellas-and-pfizer-announce-positive-top-line-results

09:04 EST 20 Dec 2018 | Odi Bruckman

Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer https://www.prnewswire.com/news-releases/astellas-and-pfizer-announce-positive-top-line-results-from-phase-3-arches-trial-of-xtandi-enzalutamide-in-men-with-metastatic-hormone-sensitive-prostate-cancer-300769270.html …

Original Article: #Astellas $PFE Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer https://www.prnewswire.com/news-releases/astellas-and-pfizer-announce-positive-top-line-results

NEXT ARTICLE

More From BioPortfolio on "#Astellas $PFE Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer https://www.prnewswire.com/news-releases/astellas-and-pfizer-announce-positive-top-line-results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...